City of Hope Comprehensive Cancer Center — Duarte, California

Public research footprint of City of Hope Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

740

Registered studies

271

Active

100

Recruiting now

379

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Non-Cutaneous Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Lung Non-Squamous Non-Small Cell Carcinoma · Myelodysplastic Syndrome With Excess Blasts-1

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)
NCT04847453 — Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at City of Hope Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.